get a key
steadybase-$ company HURA
account_id none on file
legal_name TuHURA Biosciences, Inc./NV
ticker HURA
cik 1498382
domain tuhurabio.com
entry_point_account_id none on file
name TuHURA Biosciences Inc.
exchange Nasdaq
sector Health Care
hq Tampa, FL, United States
calls 0 filings 3 executives 3 family 0
why_nownone on file
callsnone on file
filings
Dearborn’s employment agreement also provides that he will serve as the Chief Financial Officer of our company. Upon the expiration of the initial two-year

filing / Jul 9, 2026 / receipt

This process, which is commonly referred to as “householding,” provides cost savings for companies. Some brokers household proxy materials, delivering a single proxy statement, Notice or notice to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders.

filing / Jul 9, 2026 / receipt

Manuso is an author of numerous chapters, articles, patents and books on topics including health care cost containment and biotechnology company foundation and management.

filing / Jul 9, 2026 / receipt

executives
Craig Tendler director - receipt
Robert E. Hoffman director - receipt
Saiid Zarrabian Interim Chief Executive Officer - receipt
familynone on file
upcoming
2026-11-13 earnings call scheduled ir
changes
2025-03-12 director, appointed sec_8k
2023-11-21 Chief Scientific Officer, departed sec_8k
2023-06-02 Chief Financial Officer, departed sec_8k
2023-06-02 director, appointed sec_8k
2021-11-12 President and Chief Executive Officer, appointed sec_8k
2017-11-08 Interim Chief Executive Officer, appointed sec_8k
mcp_package_hint
steadybase-$